Movers & Shakers - Spark Newswire

1 minute read

ReShape Lifesciences Shares Soar As FDA Announced Clearance To GIBI HD Calibration Tubes In Weight Loss Procedures

Today, 10:12 AM

The U.S. Food and Drug Administration (FDA) has announced 510(k) clearance to ReShape Lifesciences’ (NASDAQ: RSLS) Gastro Intestinal Balloon Indicator (GIBI HD) calibration tube for use in gastric and bariatric surgical procedures.

RSLS

1 minute read

Ford To Raise Price Of 2023 F-150 Lightning By Up To $8500: Here’s Why

By Dylan Wechsler

Today, 10:12 AM

On Tuesday, the Ford Motor Company (NYSE: F) announced price hikes to its EV pickup truck, the F-150 Lightning, CNBC reported.

1 minute read

NeuroOne Seeks Again FDA Clearance For sEEG Electrode In Brain Mapping Diagnostics

By Ragothaman Srinivasan

Today, 10:12 AM

NeuroOne Medical Technologies (NASDAQ: NMTC) has submitted a special 510(k) to the U.S. Food and Drug Administration (FDA) for its sEEG electrode to extend the duration of use from less than 24 hours to less than 30 day use.

NMTC

1 minute read

Trump’s Digital World Acquisition Corp Is Down Today After FBI Raids Mar-A-Lago: Here’s What You Should Know

By Dylan Wechsler

Today, 10:12 AM

Shares of Digital World Acquisition Corp (NASDAQ: DWAC) are down Tuesday morning following the FBI’s raid of Mar-A-Lago. Why Is It Moving?

DWAC

4 minute read

Canopy Growth & Other Cannabis Operators Just Made Some Key Executive Changes You Should Know About

By Jelena Martinovic

Today, 10:12 AM

As Benzinga Cannabis Capital Conference returns on September 13-14 to Chicago, gathering top CEOs, investors and leaders in the industry, let's scroll through the latest leadership changes within the space.

CGC

2 minute read

Alnylam Shares Shoot Higher Following Positive Clinical Results From Late-Stage ATTR Amyloidosis Therapeutics

By Ragothaman Srinivasan

Today, 10:12 AM

Alnylam (NASDAQ: ALNY) announced positive results from the APOLLO-B Phase 3 study of Patisiran for the treatment of transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy.

ALNY

1 minute read

Aerie Shares Gain Following Patient Dosing In Late-Stage Dry Eye Disease Study

By Ragothaman Srinivasan

Today, 10:12 AM

Aerie Pharmaceuticals (NASDAQ: AERI) has initiated patient dosing in the Phase 3 registrational COMET-3 study to evaluate AR-15512 ophthalmic solution as a treatment for the signs and symptoms of dry eye disease (DED).

AERI

4 minute read

What The Careful CEO Should And Shouldn’t Talk About: A Handy Guide

By Mark Fritz

Today, 10:12 AM

CEOs walk a fine line when it comes to talking about hot-button issues like transgender rights or gun control or arming transgender people to fight for the right of immigrants to have affordable health care and equal pay without enduring global warming.

GOOG

3 minute read

5 Ways The Super Rich Spend $50 Billion

By Stephen Mugo Weru

Today, 10:12 AM

What would you do if you had $50 billion? You'd probably buy everything you've ever wanted, but you still wouldn’t be able to spend all the money on yourself. Figuring out how to spend all that money would be your biggest problem. I mean, how many cars can you have? How many houses can you own? It’s pretty finite, right?

AMZN

2 minute read

5 Things You Might Not About Melinda Gates

By Chris Katje

Today, 10:12 AM

Melinda Gates is well-known as the former wife of Microsoft Corporation (NASDAQ: MSFT) co-founder Bill Gates. The couple announced in 2021 they would divorce after 27 years of marriage.

AAPL